Dmitrii V Kalinin/LinkedIn
Nov 6, 2026, 22:15
Dmitrii Kalinin: Allosteric Anticoagulation – An Alternative Strategy for Safer, Next-Generation Anticoagulants
Dmitrii Kalinin, Lecturer and Assistant Professor at the University of Galway, shared a post on LinkedIn about his recent article, published in Expert Opinion on Therapeutic Patents, adding:
“Some thoughts on allosteric anticoagulation, an alternative strategy in the search for safer, next-generation anticoagulants.”
Title: Allosteric anticoagulation: emerging non-orthosteric inhibitors of factor XI and factor XIa
Authors: Dmitrii Kalinin
Stay updaed on all scientific advances with Hemostasis Today.
-
Nov 6, 2026, 15:11Sophia Delicou: Discussing Real World Mitapivat Case Studies at the 37th Panhellenic Hematology Congress
-
Nov 6, 2026, 14:57Rahul Thakur: Pretransplant Biomarkers Linked to Post Transplant GVHD and Survival at ASH 2026
-
Nov 6, 2026, 14:46ASH 2026 Outlines Visa Guidance and Flexible Registration for International Attendees
-
Nov 6, 2026, 14:39Ney Carter Borges: Intensive LDL-C Lowering and Coronary Plaque Regression
-
Nov 6, 2026, 14:34William Wallace: Visceral Fat Drives the Broadest Inflammatory Protein Signature Among Cardiometabolic Traits
-
Nov 6, 2026, 14:28Akshat Jain: Completing a Milestone Speaker Circuit with Gene Therapy and VWD Presentations at ASH 2026
-
Nov 6, 2026, 14:23Anirban Sen Gupta: Bridging Therapeutics and Diagnostics for the Future of Precision Transfusion
-
Nov 6, 2026, 14:18Ravi K. Gupta: Hematologic Care and Venous Thromboembolism Management for Transgender Patients
-
Nov 6, 2026, 14:12When Platelets Cannot Support Thrombin Generation: The Hidden Dimension of Bleeding Disorders